Metastases clinical trials at UCLA
2 in progress, 1 open to eligible people
REMASTer: REcurrent Brain Metastases After SRS Trial
open to eligible people ages 18 years and up
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Los Angeles 5368361, California 5332921 and other locations
Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Sorry, in progress, not accepting new patients
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes
Los Angeles 5368361, California 5332921 and other locations
Our lead scientists for Metastases research studies include Won Kim, MD.
Last updated: